Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78251406 | 7825140 | 6 | F | 201010 | 20160720 | 20110224 | 20160803 | EXP | US-JNJFOC-20110205228 | JANSSEN | 58.89 | YR | A | F | Y | 61.24000 | KG | 20160803 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78251406 | 7825140 | 1 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | Y | N | 0 | TABLETS | ||||||||
| 78251406 | 7825140 | 2 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | Y | N | 0 | 500 | MG | TABLETS | ||||||
| 78251406 | 7825140 | 3 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | Y | N | 0 | 500 | MG | TABLETS | ||||||
| 78251406 | 7825140 | 4 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | Y | N | 0 | TABLETS | ||||||||
| 78251406 | 7825140 | 5 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | Y | N | 0 | TABLETS | ||||||||
| 78251406 | 7825140 | 6 | PS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | Y | N | 20634 | 500 | MG | TABLETS | ||||||
| 78251406 | 7825140 | 7 | SS | MINOCYCLINE | MINOCYCLINEMINOCYCLINE HYDROCHLORIDE | 1 | Oral | U | 0 | 100 | MG | TABLETS | TIW | ||||||
| 78251406 | 7825140 | 8 | SS | DOXYCYCLINE. | DOXYCYCLINE | 1 | Unknown | U | 0 | 100 | MG | UNSPECIFIED | BID | ||||||
| 78251406 | 7825140 | 9 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 78251406 | 7825140 | 1 | Upper respiratory tract infection |
| 78251406 | 7825140 | 2 | Upper respiratory tract infection |
| 78251406 | 7825140 | 3 | Cough |
| 78251406 | 7825140 | 4 | Cough |
| 78251406 | 7825140 | 5 | Sinusitis |
| 78251406 | 7825140 | 6 | Sinusitis |
| 78251406 | 7825140 | 7 | Rheumatoid arthritis |
| 78251406 | 7825140 | 8 | Rheumatoid arthritis |
| 78251406 | 7825140 | 9 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 78251406 | 7825140 | HO |
| 78251406 | 7825140 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 78251406 | 7825140 | Adverse drug reaction | |
| 78251406 | 7825140 | Adverse event | |
| 78251406 | 7825140 | Drug hypersensitivity | |
| 78251406 | 7825140 | Hospitalisation | |
| 78251406 | 7825140 | Muscle injury | |
| 78251406 | 7825140 | Nerve compression | |
| 78251406 | 7825140 | Nerve injury | |
| 78251406 | 7825140 | Neuropathy peripheral | |
| 78251406 | 7825140 | Pain | |
| 78251406 | 7825140 | Peripheral swelling | |
| 78251406 | 7825140 | Rhabdomyolysis | |
| 78251406 | 7825140 | Tendon disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 78251406 | 7825140 | 1 | 20101025 | 0 | ||
| 78251406 | 7825140 | 2 | 20101008 | 20101017 | 0 | |
| 78251406 | 7825140 | 3 | 20101008 | 20101017 | 0 | |
| 78251406 | 7825140 | 4 | 20101025 | 0 | ||
| 78251406 | 7825140 | 5 | 20101025 | 0 | ||
| 78251406 | 7825140 | 6 | 20101008 | 20101017 | 0 | |
| 78251406 | 7825140 | 9 | 2011 | 0 |